Tauriga Sciences Inc (fka TAUG)

[rawman]

THE FOLLOWING ARTICLE CLEARLY DESCRIBES NON-EMPLOYEE CONSULTANT CEO SETH SHAW'S EARLY TIME AS THE CEO OF TAUG!

December 4, 2013

Tauriga Sciences (OTCMKTS:TAUG) is a development stage company. With a current deficit of around $35 million, the Company has $200 thousand in cash on hand and around $1.5 million in accrued liabilities as of September 2013. Tauriga has no products and services to offer and no revenues. In the period between March 2012 and September 2013, Tauriga issued over 180 million shares to fund their business bringing the total number of outstanding shares to 303 million currently. An investor in Tauriga Sciences over the past year would have lost over 80% of their investment as a result of this dilution.

In a previous article titled “The Dangers of Investing in Over The Counter (OTC) Stocks“, we looked at a number of companies that used the word “nanotechnology” to promote their value proposition, yet over time lost nearly of all their value. OTC companies claiming to be involved in similar disruptive technologies such as “3D printing”, “grapheme”, or “synthetic biology” should also be given extensive due diligence for the same reasons.

https://www.nanalyze.com/2013/12/tauriga-sciences-taug-and-pilus-energy/